AlgoTherapeutix: Clinical Trials

2 trials sponsored by AlgoTherapeutix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1

Follow AlgoTherapeutix: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EASE (Efficacy of ATX01 Study in Erythromelalgia)
Amitriptyline Hydrochloride, Placebo - Erythromelalgia
Phase 2CompletedAlgoTherapeutix142023-06-142024-04-18
Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)
ATX01 10%, ATX01 15%, Placebo - Chemotherapy-induced Peripheral Neuropathy
Phase 2Active not recruitingAlgoTherapeutix2762023-02-282024-07-16

Conditions studied

Erythromelalgia (1)

Interventions

Amitriptyline (1)

Countries

United States (2)  ·  Belgium (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)